Home › Funds › Capricorn Fund Managers Ltd › GSK

Capricorn Fund Managers Ltd position in GSK

GSK PLC ADR F · Health Care

Capricorn Fund Managers Ltd reported holding 426,416 shares of GSK (GSK PLC ADR F) in its Q2 2026 13F filing — a position valued at US$22.4M, representing 1.78% of its reported portfolio and ranking #14 among its reported holdings. Capricorn Fund Managers Ltd first reported this position in Q2 2026.

Latest position (Q2 2026)426.42K sh
Reported value held$22.35M
Portfolio Weight1.78%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Capricorn Fund Managers Ltd's GSK position evolved

Capricorn Fund Managers Ltd first disclosed a stake in GSK in Q2 2026 at 426,416 shares (US$22.4M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 426.42K $22.35M New

About GSK and 13F data

GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has Capricorn Fund Managers Ltd held GSK?

Capricorn Fund Managers Ltd has disclosed GSK holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Capricorn Fund Managers Ltd's current position in GSK?

As of Q2 2026, Capricorn Fund Managers Ltd holds 426.42K shares of GSK (GSK PLC ADR F), valued at $22.35M, representing 1.78% of its reported portfolio and ranking #14.

Has Capricorn Fund Managers Ltd been buying or selling GSK?

In the latest 13F filing (Q2 2026), Capricorn Fund Managers Ltd newly opened its position in GSK.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.